Measuring patient benefit from botulinum toxin in the treatment of dystonia. Feasibility of cost-utility analysis. (Q53589255)
Jump to navigation
Jump to search
scientific article published in December 1997
Language | Label | Description | Also known as |
---|---|---|---|
English | Measuring patient benefit from botulinum toxin in the treatment of dystonia. Feasibility of cost-utility analysis. |
scientific article published in December 1997 |
Statements
Measuring patient benefit from botulinum toxin in the treatment of dystonia. Feasibility of cost-utility analysis. (English)
C M Gudex
M R Hawthorne
A G Butler
P O Duffey
1 December 1997
12
6
675-684
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference